Aveanna Healthcare Holdings Inc.

AI-generated fair value estimate for this company.

Method: 10-year unlevered FCF DCF: $158.4M normalized free cash flow base (TTM); 6% annual FCF growth years 1-5 (toward >$2.68B 2026 revenue guidance and continued margin expansion); 3% years 6-10; 10% discount rate (leveraged healthcare-services risk); 2.5% terminal growth; $1.40B net debt subtracted; 218.22M shares outstanding.

Reasoning: Aveanna is a highly levered, capital-light home health, hospice and pediatric services provider, so an unlevered FCF DCF anchored to trailing free cash flow, with a discount rate reflecting elevated leverage and reimbursement/regulatory risk, better isolates sustainable per-share value after debt service than reported net income.